June 18, 2024

Cardiovascular Digital Solutions Market Size To Cross USD 183.23 Bn By 2032

The global cardiovascular digital solutions market size accounted for US$ 110.26 Bn in 2022 and is projected to reach around USD 183.23  Bn by 2032, growing at a CAGR of 5.21% from 2023 to 2032.

Cardiovascular Digital Solutions Market Size 2023 To 2032

Key Takeaways:

  • North America contributed more than 41% of revenue share in 2022.
  • By end-use, the hospitals and clinics segment captured over 51% of the revenue share in 2022.
  • By service type, the unobtrusive testing segment dominated the market with the highest market share of 41% in 2022, the segment will continue to grow at a significant rate during the forecast period.
  • By component, the devices segment dominated the market with the largest market share of 75% in 2022, the region is expected to maintain its dominance throughout the forecast period.
  • By deployment, the cloud-based segment generated more than 52% of revenue share in 2022.

Report Summary

The global cardiovascular digital solutions market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the cardiovascular digital solutions market across the globe.

A comprehensive estimate on the cardiovascular digital solutions market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of cardiovascular digital solutions during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3169

Cardiovascular Digital Solutions Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 116 Billion
Market Size by 2032USD 183.23 Billion
Growth Rate from 2023 to 2032CAGR of 5.21%
Largest MarketNorth America
Base Year2022
Forecast Period2023 To 2032
Segments CoveredBy Service Type, By Components, By Deployment, and By End-Use
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized cardiovascular digital solutions market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Leisure Boat Market Size To Cross USD 152.54 Bn By 2032

Cardiovascular Digital Solutions Market Players

The report includes the profiles of key cardiovascular digital solutions market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • iRythm Technologies, Inc.
  • Apple Inc.
  • GENERAL ELECTRIC COMPANY
  • Uber Diagnostics
  • AlivCor, Inc.
  • Verily Life Sciences LLC
  • HeartFlow, Inc.
  • Bardy Diagnostics, Inc.
  • Bio Telemetry, Inc.
  • Koninkelijke Philips N.V.
  • eviCore healthcare

Market Segmentation

By Service Type

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs
  • Others

By Components

  • Devices
  • Software

By Deployment

  • Cloud-Based
  • On-premises

By End-Use

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cardiovascular Digital Solutions Market 

5.1. COVID-19 Landscape: Cardiovascular Digital Solutions Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cardiovascular Digital Solutions Market, By Service Type

8.1. Cardiovascular Digital Solutions Market, by Service Type, 2023-2032

8.1.1. Unobtrusive Testing

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. CVD Health Informatics

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Cardiac Rehab Programs

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Cardiovascular Digital Solutions Market, By Components

9.1. Cardiovascular Digital Solutions Market, by Components, 2023-2032

9.1.1. Devices

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Software

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Cardiovascular Digital Solutions Market, By Deployment 

10.1. Cardiovascular Digital Solutions Market, by Deployment, 2023-2032

10.1.1. Cloud-Based

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. On-premises

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Cardiovascular Digital Solutions Market, By End-Use 

11.1. Cardiovascular Digital Solutions Market, by End-Use, 2023-2032

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Ambulatory Care Centers

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Cardiovascular Digital Solutions Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Components (2020-2032)

12.1.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.1.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Components (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Components (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Components (2020-2032)

12.2.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Components (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Components (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Components (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Components (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Components (2020-2032)

12.3.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Components (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Components (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Components (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Components (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Components (2020-2032)

12.4.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Components (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Components (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Components (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Components (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Components (2020-2032)

12.5.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Components (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Service Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Components (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Deployment (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

Chapter 13. Company Profiles

13.1. iRythm Technologies, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Apple Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. GENERAL ELECTRIC COMPANY

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Uber Diagnostics

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. AlivCor, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Verily Life Sciences LLC

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. HeartFlow, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bardy Diagnostics, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Bio Telemetry, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Koninkelijke Philips N.V.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com